Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond
Fibroblast activation protein (FAP) is a type II membrane-bound glycoprotein which is
overexpressed in cancer-associated fibroblasts and activated fibroblasts at wound …
overexpressed in cancer-associated fibroblasts and activated fibroblasts at wound …
[HTML][HTML] FAPI-avid nonmalignant PET/CT findings: an expedited systematic review
Fibroblast activation protein inhibitor (FAPI) is a promising tracer in oncologic positron
emission tomography/computed tomography (PET/CT). Numerous studies have …
emission tomography/computed tomography (PET/CT). Numerous studies have …
Pitfalls and common findings in 68Ga-FAPI PET: a pictorial analysis
L Kessler, J Ferdinandus, N Hirmas… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Fibroblast activation protein inhibitor (FAPI) PET/CT is a new tool in the diagnostic workup of
cancer. With a growing volume of applications, pitfalls and common findings need to be …
cancer. With a growing volume of applications, pitfalls and common findings need to be …
Cardiac fibroblast activation in patients early after acute myocardial infarction: integration with MR tissue characterization and subsequent functional outcome
J Diekmann, T Koenig, JT Thackeray… - Journal of Nuclear …, 2022 - Soc Nuclear Med
After acute myocardial infarction (AMI), fibroblast activation protein (FAP) upregulation
exceeds the infarct region. We sought further insights into the physiologic relevance by …
exceeds the infarct region. We sought further insights into the physiologic relevance by …
Emerging molecular imaging targets and tools for myocardial fibrosis detection
Myocardial fibrosis is the heart's common healing response to injury. While initially seeking
to optimize the strength of diseased tissue, fibrosis can become maladaptive, producing stiff …
to optimize the strength of diseased tissue, fibrosis can become maladaptive, producing stiff …
Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
X Yin, X Yin, X Pan, J Zhang, X Fan, J Li… - Frontiers in …, 2023 - frontiersin.org
Cardiac fibrosis plays an indispensable role in cardiac tissue homeostasis and repair after
myocardial infarction (MI). The cardiac fibroblast-to-myofibroblast differentiation and …
myocardial infarction (MI). The cardiac fibroblast-to-myofibroblast differentiation and …
Fibroblast activation protein imaging in reperfused ST-elevation myocardial infarction: comparison with cardiac magnetic resonance imaging
B **e, J Wang, XY **, X Guo, BX Chen, L Li… - European Journal of …, 2022 - Springer
Purpose The aim of this study was to explore the correlation of 18 F-labeled fibroblast
activation protein inhibitor (FAPI) and cardiovascular magnetic resonance (CMR) …
activation protein inhibitor (FAPI) and cardiovascular magnetic resonance (CMR) …
[68Ga]Ga-DOTA-FAPI-04 PET/MR in patients with acute myocardial infarction: potential role of predicting left ventricular remodeling
M Zhang, W Quan, T Zhu, S Feng, X Huang… - European journal of …, 2023 - Springer
Purpose To assess predictive value of 68Ga-labeled fibroblast activation protein inhibitor-04
([68Ga] Ga-DOTA-FAPI-04) PET/MR for late left ventricular (LV) remodeling in patients with …
([68Ga] Ga-DOTA-FAPI-04) PET/MR for late left ventricular (LV) remodeling in patients with …
Myocardial fibrosis: emerging target for cardiac molecular imaging and opportunity for image-guided therapy
FM Bengel, J Diekmann, A Hess… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Myocardial fibrosis is a major contributor to the development and progression of heart
failure. Significant progress in the understanding of its pathobiology has led to the …
failure. Significant progress in the understanding of its pathobiology has led to the …
Multimodality advanced cardiovascular and molecular imaging for early detection and monitoring of cancer therapy-associated cardiotoxicity and the role of artificial …
Cancer mortality has improved due to earlier detection via screening, as well as due to novel
cancer therapies such as tyrosine kinase inhibitors and immune checkpoint inhibitions …
cancer therapies such as tyrosine kinase inhibitors and immune checkpoint inhibitions …